Amphastar Pharmaceuticals, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 11570 6th Street, Rancho Cucamonga, California (CA) 91730, United States (USA)
- Operations here
- analysisdistributelabelmanufacturepack
- FDA identifiers
- FEI 3002936358 · DUNS 024736733
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIBioresearch Monitoring2025-04-03
- VAIDrug Quality Assurance2024-03-01
- NAIDrug Quality Assurance2021-06-22
- NAIBioresearch Monitoring2019-11-22
- NAIBioresearch Monitoring2019-11-21
- NAIBioresearch Monitoring2019-07-25
- VAIDrug Quality Assurance2017-03-31
- NAIBioresearch Monitoring2014-08-08
- VAIDrug Quality Assurance2014-08-08
- NAIBioresearch Monitoring2014-03-03
- VAIDrug Quality Assurance2013-02-06
- VAIBioresearch Monitoring2012-06-28
- VAIDrug Quality Assurance2012-06-28
- NAIBioresearch Monitoring2011-05-06
- VAIDrug Quality Assurance2011-05-06
- NAIBioresearch Monitoring2009-08-19
- VAIDrug Quality Assurance2009-08-19
Drugs this plant is listed as making
10 distinct drugs across 27 products name this site in their FDA label.
- CosyntropinAmphastar Pharmaceuticals, Inc.
- enoxaparin sodiumAmphastar Pharmaceuticals, Inc.
- Ganirelix AcetateAmphastar Pharmaceuticals, Inc.
- GlucagonAmphastar Pharmaceuticals, Inc.
- hyaluronidaseAmphastar Pharmaceuticals, Inc.
- Medroxyprogesterone acetateAmphastar Pharmaceuticals, Inc.
- neostigmine methylsulfateAmphastar Pharmaceuticals, Inc.
- TeriparatideAmphastar Pharmaceuticals, Inc.
- VasopressinAmphastar Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.